跳至主要内容
临床试验/NCT04677322
NCT04677322终止不适用

OBSERVATIONAL STUDY TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET THROUGH THE MONITORING OF SODIUM IN URINE IN PATIENTS WITH HIGH BLOOD PRESSURE IN THE PRIMARY CARE SETTING

Instituto de Investigación Marqués de Valdecilla1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2020年9月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
终止
发起方
入组人数
2
试验地点
1
主要终点
Systolic and diastolic TA values, the upper limit being 140 (systolic) and the lower range 90 (diastolic).

研究概览

简要总结

Arterial hypertension is an independent vascular risk factor and a frequent reason for consultation in Primary Care. It generates high cardiovascular morbidity and mortality (stroke, heart disease, kidney failure and other diseases). Moreover, given that it is a modifiable factor and that there are intervention and control measures that would lead to a significant reduction in cardiovascular incidence and morbimortality, it can be stated that ETS is a major public health problem.

The approach to this risk factor can be pharmacological and non-pharmacological. The non-pharmacological approach is based on lifestyle modification. Among the measures aimed at modifying lifestyles is the restriction of daily intake of sodium in the diet. Such restriction enhances the hypotensive effect of pharmacological treatment so that its application and intensification would delay the start of pharmacological therapy, as well as avoid the need to increase the dose of antihypertensive drugs or the number of drugs to be used for the control of hypertension.

In relation to salt intake in the Spanish population, the average is above the figures of less than 5 grams per day recommended by the WHO. Sodium intake can be estimated by determining the 24-hour urine sodium concentration. In addition, there is a positive correlation between systolic and diastolic blood pressure figures and the excretion of sodium in urine.

详细描述

In the present work, with a prospective cohort observational study design, it intends to assess the effectiveness of the use of an educational program based on the follow up of a hyposodium diet and assessed through the routine use of urine sodium monitoring of the hypertensive patient in the primary care setting, in order to optimize treatment, as well as to review the clinical control in this group of patients. On the other hand, it is intended to establish guidelines in the form of practical guidelines to provide with a standardized clinical approach for primary care centers.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 40 years old.
  • Patients diagnosed with HTA (according to criteria ESC/ESH 2018) in a PA consultation or through MAP at the health center.
  • In treatment with single, double or triple antihypertensive therapy.
  • Patients with ST figures ≥
  • Patients with TD numbers ≥
  • Patients with stable antihypertensive treatment or without modifications in the treatment at least in the last month.
  • Patients who commit to follow up the study.
  • Patients who have given written informed consent.

排除标准

  • Patients with decompensated heart failure
  • Severe renal failure.
  • Decompensated liver disease.
  • Taking non-insulin antidiabetic
  • Hypertension of pharmacological origin and other causes.

结局指标

主要结局

Systolic and diastolic TA values, the upper limit being 140 (systolic) and the lower range 90 (diastolic).

时间窗: 6 months

次要结局

  • Sodium and potassium levels in 24-hour urine and isolated urine sample, with sodium limits of 20 mEq/L in a random urine sample and 40 to 220 mEq per day.(basal)
  • Sodium and potassium levels in 24-hour urine and isolated urine sample, with sodium limits of 20 mEq/L in a random urine sample and 40 to 220 mEq per day, after educational intervention.(6 months)
  • To analyze the use of antihypertensive drugs USING morisk-green test, after educational intervention(6 months)
  • To verify compliance with the hyposodium diet and pharmacological treatment through the use of EuroQol-5D questionnaires(6 months)

研究者

发起方
Instituto de Investigación Marqués de Valdecilla
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验